Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT 201 for Snoring
NCT00773591Phase 2Withdrawn
- Sponsor
- Merz
- Start
- Mar 2010
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of incobotulinumtoxinA in primary snoring, sponsored by Merz. Planned start Mar 2010; status: withdrawn.
02
Drugs
incobotulinumtoxinA
03
Conditions
primary snoring
Beyond the preview
Go deeper on NCT00773591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773591.